TipRanks
Go Ultimate55% OFF

Amneal Pharmaceuticals (2DT) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Crexont ErParkinson DiseasePhase IVRecruitingA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseDec 31, 2024
Kshn001126 150Mg, Kshn001126 300Mg, Kshn001126 600MgHealthy Postmenopausal WomenPhase ICompletedSAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal FemalesJun 08, 2024―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Amneal Pharma (DE:2DT) have in its pipeline
Amneal Pharmaceuticals DE:2DT is currently developing the following drugs: Crexont Er, Kshn001126 150Mg, Kshn001126 300Mg, Kshn001126 600Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.